FDA halts use of monoclonal antibody drugs from Regeneron, Eli Lilly that don't work vs. omicron

COVID-19 antibody drugs from Regeneron and Eli Lilly should no longer be used because they don’t work against the omicron variant, U.S. health officials said.
Source: Check out ABC 7 for more…